Bio-IT World January 18, 2022

Trends from the Trenches—Xiong Sean Liu is a Director at Novartis where he has been working to make inroads for AI in pharma. In Liu’s view, AI as a technology is already successful, but he also believes it is still in its early days for healthcare and there are still significant challenges for use. Data organization, for example, must be solved so that AI models can be put to best use. Liu and his team recently explored how electronic health records could be better populated and curated to facilitate clinical trials.

Liu recently sat down with Stan Gloss, founding partner at BioTeam, to discuss how AI and ML are going to continue impacting pharma and healthcare, especially through application to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
Regulations, Innovations and AI Define This Week in Big Tech
Why health system AI predictions can fail
10 things you may have suspected about AI but didn’t know for sure till now
Meta's new AI assistant is rolling out across WhatsApp, Instagram, Facebook and Messenger
Exclusive: Powerful new AI model accurately converts speech to text, even your company's jargon

Share This Article